Full Breakdown
Link Between Oral Bacteria and Multiple Sclerosis Severity
12/30/2025, 7:43:05 PM
Association of Fusobacterium nucleatum with Disability in MS Patients
Recent research from Hiroshima University has identified a significant correlation between high levels of the periodontal bacterium Fusobacterium nucleatum and increased disability in patients with multiple sclerosis (MS). The study, published in the journal *Scientific Reports*, analyzed tongue-coating samples from 98 patients diagnosed with MS, neuromyelitis optica spectrum disorder (NMOSD), or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Findings revealed that nearly two-thirds (61.5%) of MS patients with elevated levels of F. nucleatum fell into the moderate-to-severe disability category, as measured by the Expanded Disability Status Scale (EDSS), compared to only 18.6% of those with lower levels.
Exploring the Oral–Brain Axis
The research highlights a potential "oral–brain axis," suggesting that oral inflammation may influence the severity of neuroinflammatory diseases like MS. The study found that the association between F. nucleatum and disability was specific to MS, as similar links were not observed in NMOSD or MOGAD patients. This specificity indicates that F. nucleatum may play a unique role in MS pathology, potentially acting as a "bridge bacterium" that connects oral inflammation to neurological impairment.
Methodology and Findings
The research team employed quantitative polymerase chain reaction (PCR) to measure the abundance of four periodontal bacteria in the oral samples. They adjusted for various clinical factors, including age, disease duration, and MS subtype, and still found that high levels of F. nucleatum were associated with approximately tenfold higher odds of severe disability in MS patients. Furthermore, patients carrying F. nucleatum alongside other periodontal pathogens exhibited even greater disability.
Implications for Oral Health and MS Management
The findings suggest that oral health may be a modifiable risk factor in MS, opening avenues for potential preventive strategies. Researchers plan to conduct larger, multi-center studies to validate these associations and explore whether dental interventions, such as periodontal treatment, could influence disease activity or progression. "Ultimately, we aim to clarify how the oral–gut–brain inflammatory axis contributes to multiple sclerosis pathophysiology," stated Hiroyuki Naito, an assistant professor at Hiroshima University Hospital.
Criticism & Opposition
While the study establishes a correlation between F. nucleatum and MS severity, it does not prove causation. Critics may argue that further research is necessary to determine whether improving oral hygiene can effectively alter disease outcomes. The study's small sample size and cross-sectional design also warrant caution in interpreting the results.
What's Next
Future research will focus on larger trials to confirm the link between oral bacteria and MS severity, as well as mechanistic analyses to understand how oral pathogens may influence MS immunopathology. The potential for oral health interventions to serve as a novel target for MS management remains an intriguing prospect for both researchers and clinicians.
Verbatim Quotes
- “Fusobacterium nucleatum may act as a hidden ‘bridge bacterium’—not only bridging bacterial communities in dental biofilms, but also potentially linking oral inflammation to neurological disability,” — Masahiro Nakamori, Associate Professor, Hiroshima University Hospital
- “Because the oral cavity is a major source of chronic inflammation, clarifying its relationship with multiple sclerosis severity is important,” — Masahiro Nakamori, Associate Professor, Hiroshima University Hospital
- “Ultimately, we aim to clarify how the oral–gut–brain inflammatory axis contributes to multiple sclerosis pathophysiology and to explore whether oral health could serve as a novel target for disease modification,” — Hiroyuki Naito, Assistant Professor, Hiroshima University Hospital
